Literature DB >> 10911881

Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia.

F M Benes1, S Berretta.   

Abstract

This chapter reviews recent postmortem studies of schizophrenic brain and discusses the potential role of the amygdala in the induction of hippocampal abnormalities in this disorder. Based on available evidence, sectors CA4, CA3, and CA2, but not CA1, show preferential changes in schizophrenic subjects, although the most pronounced changes have been found in CA3 and CA2. It seems likely that the amygdala would contribute in some way to the induction of abnormalities along the trisynaptic pathway via its direct input to sectors CA3 and CA2, as well as an indirect one that involves the entorhinal cortex and its perforant path projection to the area dentata. The postmortem findings reported to date have been integrated into a working model in which decreases of inhibitory GABAergic modulation are invoked to explain the observation from a recent PET scan study (Heckers et al., 1999) that baseline metabolic activity in the hippocampus of schizophrenics is increased. In addition, however, the apparent inability of schizophrenics to increase metabolic activity in the hippocampus when challenged with a memory retrieval task may reflect a disturbance of disinhibitory modulation postulated herein to occur in sector CA3, a key relay point along the trisynaptic pathway. Overall, it seems plausible that an increase of excitatory activity entering the hippocampus from the basolateral complex via both direct and indirect pathways may make a significant contribution to the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911881     DOI: 10.1111/j.1749-6632.2000.tb06733.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  21 in total

Review 1.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

2.  Regulation of synaptic plasticity in a schizophrenia model.

Authors:  Barbara Gisabella; Vadim Y Bolshakov; Francine M Benes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

Review 3.  Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.

Authors:  Francine M Benes
Journal:  Schizophr Bull       Date:  2007-06-16       Impact factor: 9.306

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

5.  Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Authors:  Céline Risterucci; Karine Jeanneau; Stephanie Schöppenthau; Thomas Bielser; Basil Künnecke; Markus von Kienlin; Jean-Luc Moreau
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 6.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

7.  Absence of established sex differences in patients with schizophrenia on a two-dimensional object array task.

Authors:  Seth L Shipman; Elizabeth K Baker; Godfrey Pearlson; Robert S Astur
Journal:  Psychiatry Res       Date:  2009-03-10       Impact factor: 3.222

Review 8.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

9.  Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain.

Authors:  Nina Peselmann; Andrea Schmitt; Peter J Gebicke-Haerter; Mathias Zink
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-12       Impact factor: 5.270

10.  Claudin Proteins And Neuronal Function.

Authors:  Jérôme Devaux; Bozena Fykkolodziej; Alexander Gow
Journal:  Curr Top Membr       Date:  2010       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.